Abstract
Histomorphometric analysis of iliac bone samples is a key tool for studying bone metabolism and, to a lesser extent, bone mass and structure. Two types of bone metabolic activity can be distinguished: modeling and remodeling. Both processes are performed by the same effector cells, osteoblasts and osteoclasts, but differ in the way these cells are arranged. The main effect of remodeling is to renew bone, whereas modeling can lead to rapid changes in bone shape, size and mass. Standard histomorphometric analysis focuses on trabecular bone and therefore mainly provides information on remodeling. Remodeling activity changes markedly with age during development. This must be taken into account when histomorphometry is used in the pediatric setting. Remodeling disorders encountered in the context of pediatric renal bone disease include mineralization defects, as well as abnormally high remodeling activity due to secondary hyperparathyroidism or suppressed remodeling activity as a consequence of over-treatment. Children and adolescents with severe bone fragility should have a bone biopsy unless the diagnosis is obvious from noninvasive examinations. Histomorphometric analysis of transiliac bone biopsy samples is especially valuable in clinical studies, as this method provides safety and efficacy data that cannot be obtained in any other way.
References
Rauch F (2003) Bone histomorphometry. In: Glorieux FH, Pettifor J, Jueppner H (eds) Pediatric bone. Academic, San Diego, CA, pp 359–374
Parfitt AM (2003) Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 12:387–403
Frost HM (1990) Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff’s law: the bone modeling problem. Anat Rec 226:403–413
Rauch F (2005) Bone growth in length and width: the yin and yang of bone stability. J Musculoskelet Neuronal Interact 5:194–201
Parfitt AM, Travers R, Rauch F, Glorieux FH (2000) Structural and cellular changes during bone growth in healthy children. Bone 27:487–494
Rauch F, Travers R, Norman ME, Taylor A, Parfitt AM, Glorieux FH (2002) The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. Bone 31:85–89
Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM (2000) Normative data for iliac bone histomorphometry in growing children. Bone 26:103–109
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610
Jaworski ZF, Lok E, Wellington JL (1975) Impaired osteoclastic function and linear bone erosion rate in secondary hyperparathyroidism associated with chronic renal failure. Clin Orthop Relat Res 107:298–310
Kuizon BD, Salusky IB (2003) Renal osteodystrophy: Pathogenesis, diagnosis, and treatment. In: Glorieux FH, Pettifor J, Jueppner H (eds) Pediatric bone. Academic, San Diego, CA, pp 679–701
Rauch F, Schoenau E (2002) Skeletal development in premature infants: a review of bone physiology beyond nutritional aspects. Arch Dis Child Fetal Neonatal Ed 86:F82–F85
Parfitt AM (1997) Vitamin D and the pathogenesis of rickets and osteomalacia. In: Feldman D, Glorieux FH, Pike JW (eds) Vitamin D. Academic, San Diego, CA, pp 645–662
Terpstra L, Rauch F, Plotkin H, Travers R, Glorieux FH (2002) Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis. J Bone Miner Res 17:1949–1953
Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293–1299
Parfitt AM, Qiu S, Rao DS (2004) The mineralization index—A new approach to the histomorphometric appraisal of osteomalacia. Bone 35:320–325
Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L (2004) Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 43:558–565
Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377–1385
Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88:4569–4575
Groothoff JW, Offringa M, Van Eck-Smit BLF, Gruppen MP, Van De Kar NJ, Wolff ED, Lilien MR, Davin JC, Heymans HSA, Dekker FW (2003) Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int 63:266–275
Sheth RD, Perez MD, Goldstein SL (2003) Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Pediatr Nephrol 18:810–813
Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349:457–463
Acknowledgements
Thanks go to Mark Lepik for preparing the figures. The author is a Chercheur-Boursier Clinician of the Fonds de la Recherche en Santé du Québec. This work was supported by the Shriners of North America.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rauch, F. Watching bone cells at work: what we can see from bone biopsies. Pediatr Nephrol 21, 457–462 (2006). https://doi.org/10.1007/s00467-006-0025-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0025-6